AAPL   324.24 (+0.28%)
FB   230.48 (-0.97%)
GOOGL   1,437.57 (-0.33%)
AMZN   2,468.57 (+0.06%)
NVDA   351.79 (-0.35%)
MU   48.22 (+1.01%)
TSLA   886.91 (+0.61%)
AMD   53.27 (-0.17%)
T   31.42 (+1.39%)
ACB   14.69 (+1.10%)
F   6.02 (+2.03%)
GILD   73.82 (-2.51%)
DIS   119.70 (+0.80%)
NFLX   425.20 (-0.50%)
BAC   25.53 (+0.91%)
BA   153.31 (+0.00%)
AAPL   324.24 (+0.28%)
FB   230.48 (-0.97%)
GOOGL   1,437.57 (-0.33%)
AMZN   2,468.57 (+0.06%)
NVDA   351.79 (-0.35%)
MU   48.22 (+1.01%)
TSLA   886.91 (+0.61%)
AMD   53.27 (-0.17%)
T   31.42 (+1.39%)
ACB   14.69 (+1.10%)
F   6.02 (+2.03%)
GILD   73.82 (-2.51%)
DIS   119.70 (+0.80%)
NFLX   425.20 (-0.50%)
BAC   25.53 (+0.91%)
BA   153.31 (+0.00%)
AAPL   324.24 (+0.28%)
FB   230.48 (-0.97%)
GOOGL   1,437.57 (-0.33%)
AMZN   2,468.57 (+0.06%)
NVDA   351.79 (-0.35%)
MU   48.22 (+1.01%)
TSLA   886.91 (+0.61%)
AMD   53.27 (-0.17%)
T   31.42 (+1.39%)
ACB   14.69 (+1.10%)
F   6.02 (+2.03%)
GILD   73.82 (-2.51%)
DIS   119.70 (+0.80%)
NFLX   425.20 (-0.50%)
BAC   25.53 (+0.91%)
BA   153.31 (+0.00%)
AAPL   324.24 (+0.28%)
FB   230.48 (-0.97%)
GOOGL   1,437.57 (-0.33%)
AMZN   2,468.57 (+0.06%)
NVDA   351.79 (-0.35%)
MU   48.22 (+1.01%)
TSLA   886.91 (+0.61%)
AMD   53.27 (-0.17%)
T   31.42 (+1.39%)
ACB   14.69 (+1.10%)
F   6.02 (+2.03%)
GILD   73.82 (-2.51%)
DIS   119.70 (+0.80%)
NFLX   425.20 (-0.50%)
BAC   25.53 (+0.91%)
BA   153.31 (+0.00%)
Log in

NYSEAMERICAN:XXII22nd Century Group Stock Price, Forecast & News

$0.79
+0.01 (+1.28 %)
(As of 06/3/2020 09:09 AM ET)
Add
Compare
Today's Range
$0.78
Now: $0.79
$0.81
50-Day Range N/A
52-Week Range
$0.60
Now: $0.79
$2.46
Volume732,101 shs
Average Volume1.56 million shs
Market Capitalization$110.13 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
22nd Century Group, Inc., a plant biotechnology company, provides technology that allows increasing or decreasing the level of nicotine and other nicotinic alkaloids in tobacco plants, and cannabinoids in hemp/cannabis plants through genetic engineering and plant breeding. It offers premium cigarettes under the RED SUN and MAGIC brands; and SPECTRUM research cigarettes for use in independent clinical studies. The company's products under development include BRAND A, a very low nicotine content cigarette; X-22, a tobacco-based botanical medical product for use as an aid to smoking cessation; and BRAND B, a low-tar-to-nicotine ratio cigarette. It is also involved in contract manufacturing business for third-party branded tobacco products. The company has a strategic research and development agreement with Keygene N.V. to develop hemp/cannabis plants for medical and therapeutic use, and other applications. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Williamsville, New York.
Read More
22nd Century Group logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.24 out of 5 stars


Industry, Sector and Symbol

Stock Exchange NYSEAMERICAN
Industry Biotechnology
Sub-IndustryCannabis
SectorMedical
Current SymbolNYSEAMERICAN:XXII
CUSIPN/A
CIKN/A
Phone+1-716-2701523

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees82
Market Cap$110.13 million
Next Earnings Date8/5/2020 (Estimated)
OptionableOptionable

Receive XXII News and Ratings via Email

Sign-up to receive the latest news and ratings for XXII and its competitors with MarketBeat's FREE daily newsletter.

22nd Century Group (NYSEAMERICAN:XXII) Frequently Asked Questions

Do Wall Street analysts recommend investors buy shares of 22nd Century Group?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for 22nd Century Group in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for 22nd Century Group.

When is 22nd Century Group's next earnings date?

22nd Century Group is scheduled to release its next quarterly earnings announcement on Wednesday, August 5th 2020. View our earnings forecast for 22nd Century Group.

How were 22nd Century Group's earnings last quarter?

22nd Century Group Inc (NYSEAMERICAN:XXII) issued its quarterly earnings results on Thursday, March, 12th. The biotechnology company reported ($0.05) earnings per share (EPS) for the quarter. The biotechnology company earned $7.26 million during the quarter. View 22nd Century Group's earnings history.

What price target have analysts set for XXII?

1 brokers have issued twelve-month price objectives for 22nd Century Group's shares. Their forecasts range from $12.00 to $12.00. On average, they anticipate 22nd Century Group's share price to reach $12.00 in the next year. This suggests a possible upside of 1,413.1% from the stock's current price. View analysts' price targets for 22nd Century Group.

Has 22nd Century Group been receiving favorable news coverage?

News headlines about XXII stock have been trending positive on Wednesday, InfoTrie reports. InfoTrie identifies negative and positive news coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. 22nd Century Group earned a news sentiment score of 2.4 on InfoTrie's scale. They also assigned news headlines about the biotechnology company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the near future. View the latest news about22nd Century Group.

Who are some of 22nd Century Group's key competitors?

What other stocks do shareholders of 22nd Century Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other 22nd Century Group investors own include Cara Therapeutics (CARA), Canopy Growth (CGC), Novavax (NVAX), Cronos Group (CRON), Aurora Cannabis (ACB), KushCo (KSHB), Terra Tech (TRTC), Micron Technology (MU), Zynerba Pharmaceuticals (ZYNE) and Aurora Cannabis (ACBFF).

Who are 22nd Century Group's key executives?

22nd Century Group's management team includes the following people:
  • Mr. Henry Sicignano III, MBA, Pres, CEO & Director (Age 51)
  • Mr. John T. Brodfuehrer, CFO & Treasurer (Age 61)
  • Mr. Thomas L. James J.D., Esq., VP, Gen. Counsel & Sec. (Age 60)
  • James Vail, Director of Communications
  • Mr. James C. Morrison, Technical Advisor & Regulatory Affairs Consultant

What is 22nd Century Group's stock symbol?

22nd Century Group trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "XXII."

Who are 22nd Century Group's major shareholders?

22nd Century Group's stock is owned by a number of institutional and retail investors. Top institutional investors include ETF Managers Group LLC (9.64%), BlackRock Inc. (5.92%), State Street Corp (1.44%), Geode Capital Management LLC (1.18%), UBS Group AG (0.15%) and Squarepoint Ops LLC (0.15%). Company insiders that own 22nd Century Group stock include Clifford B Fleet and Thomas L James. View institutional ownership trends for 22nd Century Group.

Which institutional investors are selling 22nd Century Group stock?

XXII stock was sold by a variety of institutional investors in the last quarter, including Morgan Stanley, State Street Corp, and BlackRock Inc.. View insider buying and selling activity for 22nd Century Group.

Which institutional investors are buying 22nd Century Group stock?

XXII stock was purchased by a variety of institutional investors in the last quarter, including ETF Managers Group LLC, Squarepoint Ops LLC, Advisor Group Holdings Inc., HNP Capital LLC, Geode Capital Management LLC, SG Americas Securities LLC, JPMorgan Chase & Co., and Alliancebernstein L.P.. View insider buying and selling activity for 22nd Century Group.

How do I buy shares of 22nd Century Group?

Shares of XXII can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is 22nd Century Group's stock price today?

One share of XXII stock can currently be purchased for approximately $0.79.

How big of a company is 22nd Century Group?

22nd Century Group has a market capitalization of $110.13 million. 22nd Century Group employs 82 workers across the globe.

What is 22nd Century Group's official website?

The official website for 22nd Century Group is www.xxiicentury.com.

How can I contact 22nd Century Group?

22nd Century Group's mailing address is 9530 Main St, CLARENCE, NY 14031-1915, United States. The biotechnology company can be reached via phone at +1-716-2701523.

This page was last updated on 6/3/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.